Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

Due to the sharp price decline, the yield from the stock's dividend has climbed to 2.8%, which is higher than the S&P 500 ...

The health insurer has suffered mounting problems and backlash since the fatal shooting of former CEO Brian Thompson.

Humana recently reported robust first-quarter earnings with significant increases ... contributed to its share price decline of 10.22% over the last week. While the broader market indices like ...

Humana recently reported robust first-quarter earnings with significant increases in revenue ... contributed to its share price decline of 10.22% over the last week. While the broader market indices ...

UnitedHealth Group earlier Tuesday suspended its earnings guidance for 2025, prompting investors to pull back on shares of the company and other names in the healthcare space.

Humana's recent earnings growth and subsequent downward ... Over the past year, Humana experienced a total shareholder return decline of 15.53%, which contrasts with the broader market's gains ...

Humana beat first-quarter profit and sales estimates as it reduced costs and exited some Medicare Advantage plans.

Reports 1Q25 earnings per share (EPS ... 5 percent Affirms expected individual Medicare Advantage annual membership decline of approximately 550,000, inclusive of the impact of exiting certain ...

Earnings were offset somewhat by an ongoing decline in Medicare Advantage membership after Humana culled underperforming plans to resuscitate margins this year. However, it’s still early in 2025 ...

Humana Inc. HUM reported first-quarter 2025 adjusted earnings of $11.58 per share ... However, the upside was partly offset by a decline in investment income, a fall in overall membership and ...